Charles Ryan

Charles Ryan

President chez QUINCE THERAPEUTICS, INC.

Fortune : 78 518 $ au 31/03/2024

60 ans
Health Technology
Commercial Services
Consumer Services

Profil

Charles S.
Ryan
is currently the Director at GlycoMira LLC and a Member at New York State Bar Association.
He is also the President at Quince Therapeutics, Inc. and a Trustee at The College of Wooster.
Previously, he served as the President, Chief Executive Officer & Director at Orthobond Corp., Chief Executive Officer & Director at Neurotrope, Inc., and Chief Executive Officer & Director at Synaptogenix, Inc. He was also the President, Chief Executive Officer & Director at Travecta Therapeutics Pte Ltd.
and Petros Pharmaceuticals, Inc. Additionally, he served as the Chairman-Development Council at Stony Brook University Medical Center, Independent Director at Applied DNA Sciences, Inc., Director at New York Biotechnology Association, Inc., and Independent Director at BioRestorative Therapies, Inc. He was also a Director at ABS Materials, Inc. and GlycoMira Therapeutics, Inc. Furthermore, he served as the Chief Intellectual Property Counsel & Senior VP at Forest Laboratories, Inc. and Vice President & General Counsel at Engelhard Long Island, Inc. He was also the Chief Operating Officer at LAB21, Inc. and Vice President & General Counsel at Cold Spring Harbor Laboratory, Inc. Dr. Ryan holds a doctorate degree from Stony Brook University, a graduate degree from Western New England University School of Law, and an undergraduate degree from The College of Wooster.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
01/02/2024 74 074 ( 0,17% ) 78 518 $ 31/03/2024

Postes actifs de Charles Ryan

SociétésPosteDébut
QUINCE THERAPEUTICS, INC. President 01/09/2023
GlycoMira LLC Director/Board Member -
The College of Wooster Director/Board Member -
Corporate Officer/Principal -
Tous les postes actifs de Charles Ryan

Anciens postes connus de Charles Ryan

SociétésPosteFin
Chief Executive Officer 01/10/2022
SYNAPTOGENIX, INC. Chief Executive Officer 01/12/2020
NEUROTROPE, INC. Chief Executive Officer 01/12/2020
BIORESTORATIVE THERAPIES, INC. Director/Board Member 10/01/2020
APPLIED DNA SCIENCES, INC. Director/Board Member 07/11/2019
Voir l'expérience en détail de Charles Ryan

Formation de Charles Ryan

Stony Brook University Doctorate Degree
Western New England University School of Law Graduate Degree
The College of Wooster Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Charles Ryan

Relations

100 +

Relations au 1er degré

22

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées5
APPLIED DNA SCIENCES, INC.

Health Technology

BIORESTORATIVE THERAPIES, INC.

Health Technology

SYNAPTOGENIX, INC.

Health Technology

QUINCE THERAPEUTICS, INC.

Health Technology

PETROS PHARMACEUTICALS

Health Technology

Entreprise privées13

Health Technology

Process Industries

GlycoMira LLC

Health Technology

Commercial Services

Health Services

Commercial Services

Commercial Services

Commercial Services

Health Services

Consumer Durables

Technology Services

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Charles Ryan